mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.1 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.1 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.1 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.1 |